<!DOCTYPE html>
<html>
<head>
<title>Refpages</title>
<link rel="stylesheet" href="refstyle.css">
</head>

<body>

<!-- refpage 15---------------------------------------------------------------------------------------------------------->
<div class = "title">Centrally-acting antihypertensives</div>

<div class = "source">
<div class = "quote">
Central antihypertensives  (Table 2: Fall-risk increasing drugs (FRIDs) according to the preliminary (September 2019) European consensus list.)
</div><div class = "quote">
Item 10: Centrally-acting antihypertensives (e.g. methyldopa, clonidine, moxonidine, rilmenidine, guanfacine), unless clear intolerance or lack of efficacy with other classes of antihypertensives: High risk of adverse CNS effects; May cause bradycardia and orthostatic hypotension; Not recommended as routine treatment for hypertension: Consider other safer antihypertensive.
</div><div class="ref" name="7">
GheOP3S-tool draft 3 (2020-07-01)
</div>
</div>



</body>